Skip to main content

Table 6 Comparison of demographic, laboratory, echocardiographic data, and QTc interval in patients according to whether they were alive or dead at the beginning of a 3-month follow-up period

From: Cardiac dysfunction in patients with end-stage liver disease, prevalence, and impact on outcome: a comparative prospective cohort study

 

Alive (n= 24)

Dead (n= 16)

Test used

Pvalue

Mean

SD

Mean

SD

Age

52.2

6.9

51

6.1

Ttest

0.57

Albumin

3

0.4

2.56

0.3

0.001

bilirubin

2.5

0.6

2.7

0.5

0.36

sodium

130

2.6

131

3.5

0.53

potassium

3.6

0.3

3.7

0.4

0.92

INR

1.9

0.3

2

0.3

0.37

EF

61

6.5

62.5

5.5

0.53

MASV

12.5

2.1

12.7

1.7

0.81

E/A

1.1

0.6

1

0.7

0.66

E/E’

12.7

2.6

12.8

3

0.94

MPI

0.4

0.03

0.4

0.02

0.84

LV mass

70.5

14.4

67.5

10

0.46

LA volume

38.8

3.9

39

5.6

0.9

QT interval

457.7

26.5

446

24.3

0.16

 

N

%

N

%

 

Gender

Male

13

54%

10

62.5%

Chi square

0.6

Female

11

46%

6

37.5%

Cause of cirrhosis

Cryptogenic

4

16.7%

2

12.5%

0.53

HBV

6

25%

2

12.5%

HCV

14

58.3%

12

75%

Encephalopathy

No

9

37.5%

6

37.5%

0.22

Grade 1

12

50%

4

25%

Grade 2

2

8.3%

3

18.8%

Grade 3

1

4.2%

3

18.8%

Ascites

No

4

16.7%

0

0

<0.001

Mild

13

54.2%

1

6.3%

Moderate

7

29.2%

7

43.8%

Tense

0

0

8

50%

Diastolic dysfunction

Grade 0

1

4.2%

0

0

0.68

Grade 1

11

45.8%

10

62.5%

Grade 2

8

33.3%

4

25%

Grade 3

4

16.7%

2

12.5%

Child

Child B

15

62.5%

3

18.8%

0.006

Child C

9

37.5%

13

81.2%

  1. NS non-significant, S significant, HS highly significant, N number, EF ejection fraction, MASV mitral annular systolic velocity, TDI tissue Doppler imaging, E E wave velocity, A A-wave velocity, MPI myocardial performance index, LV left ventricular, LA left atrial, SD standard deviation